Candesartan vs Gefitinib

Candesartan vs Gefitinib: Overview

This comparison examines the pharmacological differences between Candesartan and Gefitinib.

Mechanism of Action

Candesartan: Prodrug hydrolyzed to active form; selective angiotensin II type 1 receptor blocker.

Gefitinib: Selective reversible inhibitor of EGFR tyrosine kinase.

Pharmacokinetics

Half-life: Candesartan — 9 hours; Gefitinib — 48 hours.

Chemical Properties

Molecular Formula: Candesartan — C33H34N6O6; Gefitinib — C22H24ClFN4O3.

Molecular Weight: Candesartan — 610.6640 g/mol; Gefitinib — 446.9000 g/mol.

Type: Candesartan — Small molecule; Gefitinib — Small molecule.